3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Thyroid Neoplasms
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
cc-486
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Quality of Life
1
Patient Reported Outcome Measures
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nuclear Medicine Department, Hospital
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Focus Groups
×
Plasma cell
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled